Skip to main content
. 2013 Jan 18;8(1):e53219. doi: 10.1371/journal.pone.0053219

Table 2. Baseline Characteristics for LEUVEN participants stratified for the clinical impact of airflow obstruction.

Asymptomatic smokers Ambulatory COPD patients End-stage COPD patients p-value
(n = 366) (n = 394) (n = 123)
Demographics
Age, mean (SD), yr 62.3 (5.71) 67.6 (8.67) 57.2 (4.69) <0.001
Male sex, no. (%) 286 (78.1) 305 (77.4) 62 (50.4) <0.001
Height, mean (SD), cm 172.0 (8.9) 168.6 (8.4) 165.0 (8.5) <0.001
Smoking
Pack-years history, mean (SD), yr 45.8 (21.8) 52.5 (27.3) 35.5 (19.8) <0.001
Current smokers, no. (%) 203 (55.8) 157 (40.5) 5 (15.6) <0.001
Smoked years, mean (SD), yr 40.6 (7.0) 43.2 (10.4) 36.1 (8.2) <0.001
Years quit smokers, median (25th–75th percentiles) 0.0 (0.0–7.0) 2.0 (0.0–9.0) 3.0 (1.0–6.0) <0.001
Pulmonary function tests, mean (SD)
FEV1, L 2.91 (0.74) 1.38 (0.63) 0.70 (0.30) <0.001
FEV1, % predicted 96.4 (18.3) 49.3 (20.1) 25.5 (9.9) <0.001
FEV1/FVC ratio 0.70 (0.09) 0.45 (0.13) 0.33 (0.08) <0.001
COPD severity, no. (%)
No Obstruction 218 (59.6) 11 (2.8) 0 (0) <0.001
GOLD class I 96 (26.2) 27 (6.9) 1 (0.8)
GOLD class II 46 (12.6) 134 (34.0) 3 (2. 4)
GOLD class III 6 (1.6) 157 (39.8) 25 (20.3)
GOLD class IV 0 (0) 65 (16.5) 94 (76.4)

Abbreviations are the same as in Table 1. Percentages are column percentages. The 366 asymptomatic smokers are population-based participants of the Dutch-Belgian lung cancer screening trial (NELSON). None of them were previously diagnosed with COPD. However, 148 subjects (40.4%) were found to have an obstructive lung function (based on FEV1/FVC<0.70) at inclusion. Eleven subjects (2%), that were followed-up at the outpatient clinic because of symptoms compatible with COPD, did not fulfill the criterion of COPD (FEV1/FVC>0.70). Five patients with end-stage COPD were not actively listed for lung transplantation because of their current smoking status at inclusion.